\begin{tabular}{l*{3}{c}}
\hline\hline
            Variable&\multicolumn{1}{c}{Time frame}&\multicolumn{1}{c}{Total Prescriptions}&\multicolumn{1}{c}{Weighted Proportion}\\
\hline
\textbf{Total Sample}                                   &     Years 2006-2016&                          3340&     .00861\\
                                                        &     Before Entry of Generic&    1931&     .00856\\
                                                        &     After Entry of Generic&      1409&     .0087\\
[1em]
\textbf{OffLabel}                                       &     Years 2006-2016&             2736&     .00718\\
(=1 if no diagnoses made were FDA approved         &     Before Entry of Generic&    1548&     .007\\
indications of Sulfamethoxazole-Trimethoprim)  &     After Entry of Generic&      1188&     .00749\\
[.5em]
(=0 if at least one diagnosis made during               &     Years 2006-2016&             604&     .0507\\
visit is an FDA approved indication of                  &     Before Entry of Generic&    383&     .0535\\
Sulfamethoxazole-Trimethoprim)                          &     After Entry of Generic&      221&     .0478\\
[.5em]
\textbf{GovInsurance}                                   &     Years 2006-2016&             869&     .00871\\
(=1 if patient is on either Medicare of Medicaid)       &     Before Entry of Generic&     488 &     .00803\\
                                                        &     After Entry of Generic&      381 &     .0097\\
[.5em]
(=0 if patient is on neither Medicare nor Medicaid)     &     Years 2006-2016&             2471&     .00858\\
                                                        &     Before Entry of Generic&     383 &     .00873\\
                                                        &     After Entry of Generic&      1028 &     .00831\\
[.5em]
\textbf{NonWhite}                                       &     Years 2006-2016&             534&      .00933\\
(=1 if patient is race other than white)                &     Before Entry of Generic&     336&      .00857\\
                                                        &     After Entry of Generic&      198&      .0105\\
[.5em]
(=0 if patient is white)                                &     Years 2006-2016&             2806&      .00847\\
                                                        &     Before Entry of Generic&     1595&      .00856\\
                                                        &     After Entry of Generic&      1211&      .00832\\
\hline
$\text{Sample Size for Years 2006-2016 }= 399245$\\
$\text{Sample Size before Entry of Generic} = 230182$\\
$\text{Sample Size after Entry of Generic} = 169063$\\
\hline\hline
\multicolumn{4}{l}{\footnotesize All observations after August 2012 are considered to be after entry of generic.}\\
\end{tabular}


%multicolumn{5}{l}{"Share of Sample" and "Proportion Prescribed ST" are both weighted proportions}\\
%\multicolumn{5}{l}{offLabel(=1) indicates no diagnoses made were on label indicators, govInsurance(=1) indicates patient is on Medicare or Medicaid,}\\
%\multicolumn{5}{l}{nonWhite(=1) indicates patient is race other than white}\\
%\end{tabular}
%\label{tab:Table4.2}
%\end{table}
